Application 019886
- Type
- NDA
- Sponsor
- GD SEARLE LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SYNAREL | NAFARELIN ACETATE | SPRAY, METERED;NASAL | EQ 0.2MG BASE/SPRAY | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0025-0166 | Synarel | nafarelin acetate | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-0166 | Synarel | nafarelin acetate | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-0166 | Synarel | nafarelin acetate | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-0166 | Synarel | nafarelin acetate | G.D. Searle LLC Division of Pfizer Inc | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84310 | SUPPL | 2025-11-25 |
| 84303 | SUPPL | 2025-11-25 |
| 84302 | SUPPL | 2025-11-25 |
| 73402 | SUPPL | 2023-02-07 |
| 73355 | SUPPL | 2023-02-01 |
| 70831 | SUPPL | 2022-04-27 |
| 70830 | SUPPL | 2022-04-27 |
| 70807 | SUPPL | 2022-04-26 |
| 48496 | SUPPL | 2017-05-23 |
| 48495 | SUPPL | 2017-05-23 |
| 48480 | SUPPL | 2017-05-22 |
| 48479 | SUPPL | 2017-05-22 |
| 48478 | SUPPL | 2017-05-22 |
| 48477 | SUPPL | 2017-05-22 |
| 19793 | SUPPL | 2015-08-11 |
| 11814 | SUPPL | 2015-08-10 |
| 1764 | SUPPL | 2012-01-17 |
| 34068 | SUPPL | 2012-01-12 |
| 34067 | SUPPL | 2011-01-11 |
| 11813 | SUPPL | 2011-01-11 |
| 19792 | SUPPL | 2011-01-07 |
| 1763 | SUPPL | 2011-01-07 |
| 34066 | SUPPL | 2006-04-13 |
| 1762 | SUPPL | 2006-04-13 |
| 20406 | SUPPL | 1999-07-21 |
| 1761 | SUPPL | 1998-12-24 |